控制转速下静脉-动脉体外膜肺氧合撤机时自体血回输的效果与安全性分析
该回顾性研究纳入2023年1月至2024年5月在河南省第三人民医院急诊与重症医学中心成功撤机的62例VA-ECMO患者,按撤机后有无血液回输分为观察组与对照组各31例。观察组撤机后BNP、PaCO2、动脉乳酸、CVP及右心负荷较撤机前显著降低,Hb、PaO2、下腔静脉塌陷指数及LVEF较撤机前显著升高,但上述参数与对照组比较均无显著差异。撤机后3天观察组体温、WBC、NEU%、CRP、PCT、IL-10较撤机后1天显著降低,与对照组比较无显著差异。两组感染、血栓、肾功能衰竭、消化道出血等并发症发生率无显著差异。结论认为控制转速下VA-ECMO撤机时自体血回输安全有效,不增加感染或血栓风险。
要点
- 62例成功撤机VA-ECMO患者中,撤机后血液回输组与未回输组各31例,基线性别、年龄、BMI、EuroScore无显著差异。
- 观察组撤机后BNP、PaCO2、动脉乳酸、CVP、右心负荷较撤机前显著降低,Hb、PaO2、下腔静脉塌陷指数、LVEF较撤机前显著升高(均P<0.05)。
- 上述撤机前后变化在观察组与对照组之间均无显著差异。
- 观察组撤机后3天体温、WBC、NEU%、CRP、PCT、IL-10较撤机后1天显著降低(均P<0.05),与对照组比较无显著差异。
- 两组感染、血栓、肾功能衰竭、消化道出血发生率无显著差异。
适用人群与场景
- 2023年1月至2024年5月在河南省第三人民医院急诊与重症医学中心接受ECMO并成功撤机的患者。
- 研究为回顾性研究,按撤机后有无血液回输分为观察组(有回输)与对照组(无回输),每组31例。
研究设计与关键结果
- 研究类型为回顾性研究,共纳入62例成功撤机VA-ECMO患者,观察组与对照组各31例。
- 两组基线性别、年龄、BMI、EuroScore无显著差异;撤机时心率、SBP、DBP、外周血氧饱和度无显著差异。
- 观察组撤机后BNP(ng/L)2 325.96±78.51 vs 撤机前4 878.48±185.47,PaCO2(mmHg)35.23±3.25 vs 40.75±4.41,动脉乳酸(mmol/L)2.43±0.61 vs 6.19±1.31,CVP(cmH2O)8.32±0.97 vs 15.34±1.74,右心负荷13.24±0.97 vs 15.69±1.31,均较撤机前显著降低(P<0.05)。
- 观察组撤机后Hb(g/L)104.42±9.78 vs 撤机前96.74±6.39,PaO2(mmHg)94.12±7.78 vs 75.51±4.39,下腔静脉塌陷指数(%)28±7 vs 17±3,LVEF(%)62.41±6.49 vs 45.30±4.51,均较撤机前显著升高(P<0.05)。
- 上述撤机前后参数在观察组与对照组之间均无显著差异。
- 观察组撤机后3天较撤机后1天:体温(℃)36.83±1.15 vs 37.94±1.41,WBC(×10^9/L)7.82±0.96 vs 14.34±2.15,NEU% 0.71±0.05 vs 0.80±0.07,CRP(mg/L)4.34±0.78 vs 8.94±1.21,PCT(μg/L)0.11±0.02 vs 0.26±0.05,IL-10(ng/L)8.93±1.52 vs 13.51±2.17,均显著降低(P<0.05),与对照组比较无显著差异。
- 两组感染、血栓、肾功能衰竭、消化道出血发生率无显著差异。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,控制转速下VA-ECMO撤机时行自体血回输安全有效,不增加感染或血栓风险。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the efficacy and safety of autologous blood transfusion during weaning from venous-arterial extracorporeal membrane oxygenation (VA-ECMO) under controlled rotational speed.
METHODS: A retrospective study was conducted, selecting patients who underwent extracorporeal membrane oxygenation (ECMO) and successfully weaned at the emergency and critical care medicine center of Henan Provincial Third People's Hospital from January 2023 to May 2024. General data including gender, age, body mass index (BMI), European system for cardiac operative risk evaluation (EuroScore), and disease types were collected. Vital signs at weaning [heart rate, systolic blood pressure (SBP), diastolic blood pressure (DBP), and peripheral oxygen saturation], parameters before and after weaning [B-type natriuretic peptide (BNP), hemoglobin (Hb), partial pressure of arterial oxygen (PaO2), partial pressure of arterial carbon dioxide (PaCO2), arterial lactate, central venous pressure (CVP), inferior vena cava collapsibility index, left ventricular ejection fraction (LVEF), and right heart load], post-weaning inflammatory markers at 1-day and 3-day [body temperature, white blood cell count (WBC), neutrophil percentage (NEU%), C-reactive protein (CRP), procalcitonin (PCT), interleukin-10 (IL-10)], as well as complications (infection, thrombosis, renal failure, gastrointestinal bleeding) and post-weaning blood return status were recorded. Patients were divided into an observation group (with post-weaning blood return) and a control group (without post-weaning blood return) based on the presence of blood return after weaning. The changes in the aforementioned parameters were compared between the two groups.
RESULTS: A total of 62 patients were included, with 31 cases in each group. No statistically significant differences were observed between the two groups in baseline characteristics including gender, age, BMI, and EuroScore. At weaning, the observation group exhibited relatively stable vital signs, with no significant differences in heart rate, SBP, DBP, or peripheral oxygen saturation compared to the control group. After weaning, the observation group showed significantly lower levels of BNP, PaCO2, arterial lactate, CVP, and right heart load compared to pre-weaning values [BNP (ng/L): 2 325.96±78.51 vs. 4 878.48±185.47, PaCO2 (mmHg, 1 mmHg≈0.133 kPa): 35.23±3.25 vs. 40.75±4.41, arterial lactate (mmol/L): 2.43±0.61 vs. 6.19±1.31, CVP (cmH2O, 1 cmH2O≈0.098 kPa): 8.32±0.97 vs. 15.34±1.74, right heart load: 13.24±0.97 vs. 15.69±1.31, all P < 0.05], while Hb, PaO2, inferior vena cava collapsibility index, and LVEF were significantly higher than pre-weaning values [Hb (g/L): 104.42±9.78 vs. 96.74±6.39, PaO2 (mmHg): 94.12±7.78 vs. 75.51±4.39, inferior vena cava collapsibility (%): 28±7 vs. 17±3, LVEF (%): 62.41±6.49 vs. 45.30±4.51, all P < 0.05]. No statistically significant differences were found between the observation group and control group in these parameters. At 3 days post-weaning, the observation group demonstrated significantly lower levels of body temperature, WBC, NEU%, CRP, PCT, and IL-10 compared to 1 day post-weaning [body temperature (centigrade): 36.83±1.15 vs. 37.94±1.41, WBC (×109/L): 7.82±0.96 vs. 14.34±2.15, NEU%: 0.71±0.05 vs. 0.80±0.07; CRP (mg/L): 4.34±0.78 vs. 8.94±1.21, PCT (μg/L): 0.11±0.02 vs. 0.26±0.05, IL-10 (ng/L): 8.93±1.52 vs. 13.51±2.17, all P < 0.05], with no significant differences compared to the control group. No statistically significant differences were observed between the two groups in the incidence of complications including infection, thrombosis, renal failure, and gastrointestinal bleeding.
CONCLUSION: Autologous blood reinfusion during VA-ECMO weaning under controlled rotational speed is safe and effective, without increasing risks of infection or thrombosis.
参考来源
- Xu Z, Geng Y, Wang C, et al. [Analysis of the effect and safety of autologous blood reinfusion during venous-arterial extracorporeal membrane oxygenation weaning under controlled rotational speed]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 40820537. doi:10.3760/cma.j.cn121430-20250117-00066
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。